Eosinophilic Disorders
Showing 1 - 25 of >10,000
Eosinophilic Gastrointestinal Disorders, Eosinophilic Esophagitis, Eosinophilic Gastritis or Gastroenteritis Trial in Pavia
Recruiting
- Eosinophilic Gastrointestinal Disorders
- +3 more
-
Pavia, ItalyIRCCS Policlinico San Matteo
Feb 3, 2022
BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of
Recruiting
- BCR-JAK2 Fusion Protein Expression
- +11 more
-
Palo Alto, California
- +3 more
Oct 5, 2022
Study of Gastric Motility in EG
Recruiting
- Eosinophilic Gastritis
- +2 more
-
Chicago, Illinois
- +2 more
Dec 16, 2022
Elucidate the Mechanisms of Eosinophilic Disorders
Recruiting
- Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease
- Food Allergy
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 5, 2021
Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Eosinophilic Colitis Trial in Chicago
Recruiting
- Eosinophilic Esophagitis
- +3 more
-
Chicago, IllinoisAnn & Robert H Lurie Children's Hospital of Chicag
Jan 24, 2022
Measures in Eosinophilic Gastrointestinal Disorders Across Ages
Recruiting
- Eosinophilic Gastrointestinal Disorders (EGIDs)
- +4 more
-
Rogers, Arkansas
- +17 more
Jan 31, 2023
Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting
- Severe Eosinophilic Asthma
- +16 more
- no study intervention. Patients receive standard clinical care
-
Southampton, Hampshire, United Kingdom
- +1 more
May 4, 2022
Somatization, Anxiety, and Disordered Sleep in Pediatric
Recruiting
- Eosinophilic Esophagitis
-
San Diego, CaliforniaRady Children's Hospital San Diego
May 3, 2021
Eosinophilic Esophagitis (EoE) Trial in United States (Oral Budesonide Suspension (MB-9), Placebo)
Completed
- Eosinophilic Esophagitis (EoE)
- Oral Budesonide Suspension (MB-9)
- Placebo
-
Phoenix, Arizona
- +22 more
May 19, 2021
Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis) Trial in Ghent (Rituximab)
Completed
- Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
-
Ghent, BelgiumUniversity Hospital Ghent
Jul 7, 2021
Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)
Recruiting
- Primary Myelofibrosis
- +9 more
- Observational
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 11, 2022
Eosinophilic Esophagitis, Connective Tissue Disorders Trial in Mason (Losartan Potassium)
Completed
- Eosinophilic Esophagitis
- Connective Tissue Disorders
- Losartan Potassium
-
Mason, OhioKara Kliewer
Sep 23, 2020
Eosinophilic Gastrointestinal Disorders (EGIDs), Eosinophilic Esophagitis (EoE) Trial in United States (1 Food Elimination Diet
Completed
- Eosinophilic Gastrointestinal Disorders (EGIDs)
- Eosinophilic Esophagitis (EoE)
- 1 Food Elimination Diet Therapy
- +3 more
-
La Jolla, California
- +8 more
May 18, 2020
Eosinophilic Colitis Trial (colonoscopy)
Not yet recruiting
- Eosinophilic Colitis
- colonoscopy
- (no location specified)
Feb 9, 2023
Eosinophilic Esophagitis Trial in Jacksonville (Famotidine, Loratadine, Placebo)
Terminated
- Eosinophilic Esophagitis
- Famotidine
- +2 more
-
Jacksonville, FloridaMayo Clinic
Nov 28, 2022
Eosinophilic Esophagitis Trial in Indianapolis, Boston, Melbourne (APT-1011, Placebo oral tablet)
Completed
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Indianapolis, Indiana
- +2 more
Nov 13, 2022
Eosinophilic Gastritis, Enteritis, and Colitis inMulti-Site
Completed
- Eosinophilic Esophagitis
- +3 more
-
Little Rock, Arkansas
- +5 more
Sep 27, 2021
Eosinophilic Esophagitis Trial in Worldwide (Etrasimod, Placebo)
Active, not recruiting
- Eosinophilic Esophagitis
- Etrasimod
- Placebo
-
Birmingham, Alabama
- +222 more
Dec 8, 2022
Functional Chest Pain Trial in Amsterdam (Citalopram 20mg, Placebo)
Terminated
- Functional Chest Pain
- Citalopram 20mg
- Placebo
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location AMC
Feb 9, 2023
Activation and Function of Eosinophils in Conditions With Blood
Recruiting
- Immune System Diseases
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Eosinophilic Esophagitis Trial in Milan (esophagogastroduodenoscopy (EGD), buccal swab, blood withdrawal)
Withdrawn
- Eosinophilic Esophagitis
- esophagogastroduodenoscopy (EGD), buccal swab, blood withdrawal
-
Milan, Milano, ItalyIRCCS San Raffaele Hospital
May 31, 2023
Eosinophilic Esophagitis Trial in United States (APT-1011, Placebo oral tablet)
Recruiting
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Colorado Springs, Colorado
- +4 more
Jan 4, 2023
Eosinophilic Esophagitis Trial in Rochester (Cytosponge)
Terminated
- Eosinophilic Esophagitis
- Cytosponge
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 10, 2022
Eosinophilic Esophagitis Trial in Camarillo, Bozeman (APT-1011 3 mg HS)
Available
- Eosinophilic Esophagitis
- APT-1011 3 mg HS
-
Camarillo, California
- +1 more
Jun 15, 2022
Eosinophilic Gastritis, Eosinophilic Gastroenteritis Trial in Worldwide (Benralizumab, Placebo)
Recruiting
- Eosinophilic Gastritis
- Eosinophilic Gastroenteritis
- Benralizumab
- Placebo
-
Phoenix, Arizona
- +85 more
Aug 4, 2022